Core F -Clinical Science Core
核心 F - 临床科学核心
基本信息
- 批准号:10458375
- 负责人:
- 金额:$ 21.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-08 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS clinical trial groupAffectAgingAreaBehavioralBehavioral ResearchBiomedical ResearchCaliforniaClinicClinicalClinical DataClinical InformaticsClinical ProtocolsClinical SciencesCohort StudiesCollaborationsCollectionCommunitiesConceptionsConsent FormsConsultationsDataDevelopmentElectronic Health RecordEpidemicEthics CommitteesFundingGoalsGrantHIVHIV SeropositivityHIV prevention trials networkHumanHuman Subject ResearchIndividualInstitutional Review BoardsInternationalInterventionInvestigational New Drug ApplicationLaboratoriesLeadLinkLos AngelesMissionMonitorParticipantPatient RecruitmentsPharmacy facilityPoliciesPopulationPreventionProcessProtocols documentationRegistriesResearchResearch DesignResearch PersonnelResearch TrainingResourcesSamplingScienceServicesSpecimenStandardizationStatistical MethodsTargeted ResearchTimeTrainingTraining SupportTraining and EducationTranslational ResearchTranslationsUnderrepresented PopulationsUniversitiesUniversity resourcesVeteransVulnerable PopulationsWorkbaseclinical research sitecommunity engagementdesignearly phase trialefficacious interventionexperiencefirst-in-humanhigh rewardhigh riskhuman subjectimplementation frameworkimplementation scienceinstitutional biosafety committeeinterestnovelpatient orientedpatient oriented researchpre-clinicalpreventprospectiveprotocol developmentresearch studysociodemographicssymposiumvolunteer
项目摘要
CORE F: PROJECT SUMMARY/ABSTRACT. The Clinical Science Core provides support for clinical,
basic/translational, and behavioral investigators in the conduct of HIV-related research involving human subjects
at the University of California, Los Angeles (UCLA), Charles Drew University (CDU), and affiliated centers. The
goal of Core F is to support the translation of preliminary and pre-clinical data and ideas into clinical/human
studies that advance HIV science and lead to interventions with potential quantifiable impact on the HIV
epidemic. The Core will do this by reducing identified barriers to the development and implementation of patient-
oriented research. The Core has two Specific Aims: 1. To provide support and training to investigators in the
regulatory approval and implementation aspects of biomedical, behavioral, and basic translational patient-
oriented research in HIV, and 2. To facilitate patient-oriented research in HIV by increasing access to research
participants and generating new collaborations and concepts. The Core offers a streamlined process and
consultative services to reduce the time between project conception and funding (supporting clinical protocol
development and feasibility assessment for successful grant submissions); reduce the time between funding and
the initiation and completion of the research; train and support new investigators and established investigators
new to patient-oriented research in regulatory, design, and implementation aspects of human subjects research,
to move novel and efficacious interventions from the lab to the clinic (domestically and globally); support
mechanistic work that can lead to clinical interventions by increasing access to human samples; promote
collaboration through linkage to HIV research networks and data; and engage underrepresented populations in
HIV research through the Research Study Volunteer Project (RSVP), a Core-sponsored volunteer registry for
individuals with and without HIV interested in participating in HIV-related research, to generate the most
informative prevention and treatment studies in key populations. All services of the Core will support both
domestic and internationally based research initiatives.
核心F:项目摘要/摘要。临床科学核心为临床提供支持,
基本/翻译和行为研究者在涉及人类受试者的HIV相关研究中
在加利福尼亚大学,洛杉矶分校(加州大学洛杉矶分校),查尔斯·德鲁大学(CDU)和附属中心。这
核心F的目标是支持将初步和临床前数据和思想转化为临床/人
提高艾滋病毒科学并导致对艾滋病毒有潜在可量化影响的干预措施的研究
流行性。核心将通过减少确定的患者发展和实施障碍来做到这一点。
定向研究。核心有两个具体的目标:1。向调查人员提供支持和培训
生物医学,行为和基本转化患者的监管批准和实施方面
艾滋病毒的定向研究和2。通过增加研究的机会来促进艾滋病毒的艾滋病毒研究
参与者并产生新的合作和概念。核心提供了简化的过程,
咨询服务以减少项目构想和资金之间的时间(支持临床协议
成功赠款提交的发展和可行性评估);减少资金和
研究的启动和完成;培训并支持新的调查人员,并建立了调查员
人类受试者研究的监管,设计和实施方面研究的新知识研究,
将新颖有效的干预措施从实验室转移到诊所(在国内和全球);支持
通过增加获得人类样本的机会,可以导致临床干预的机理工作;推动
通过与艾滋病毒研究网络和数据联系的协作;并参与代表性不足的人群
艾滋病毒研究通过研究研究志愿者项目(RSVP),这是由核心赞助的志愿者注册表
患有和没有艾滋病毒的人有兴趣参与与HIV相关的研究,以产生最多的人
关键人群的信息预防和治疗研究。核心的所有服务都将支持两者
国内和国际研究计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kara W Chew其他文献
Kara W Chew的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kara W Chew', 18)}}的其他基金
相似国自然基金
来源和老化过程对大气棕碳光吸收特性及环境气候效应影响的模型研究
- 批准号:42377093
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
内源DOM介导下微塑料的老化过程及对植物的影响机制
- 批准号:42377233
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
老化过程对沙尘辐射效应和反馈机制的影响研究
- 批准号:42375107
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
生物炭原位修复底泥PAHs的老化特征与影响机制
- 批准号:42307107
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
河口潮滩中轮胎磨损颗粒的光老化特征及对沉积物氮素转化的影响与机制
- 批准号:42307479
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Hormone Therapy for Peri- and Postmenopausal Women with HIV (HoT)
感染艾滋病毒的围绝经期和绝经后妇女的激素治疗 (HoT)
- 批准号:
10698682 - 财政年份:2023
- 资助金额:
$ 21.01万 - 项目类别:
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
艾滋病毒及相关感染治疗研究艾滋病临床试验小组
- 批准号:
10493539 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
SARS-CoV-2 抗病毒核糖核苷类似物对线粒体 DNA 的影响
- 批准号:
10448062 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别:
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
SARS-CoV-2 抗病毒核糖核苷类似物对线粒体 DNA 的影响
- 批准号:
10557154 - 财政年份:2022
- 资助金额:
$ 21.01万 - 项目类别: